n(g),n(g')-dimethyl-l-arginine has been researched along with Glaucoma in 4 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA), a potent endogenous inhibitor of nitric oxide synthase, may be involved in the pathophysiology of glaucoma by dysfunctioning nitric oxide and oxidative stress." | 8.02 | Association Between the Asymmetric Dimethylarginine Levels and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study. ( Miyata, K; Obayashi, K; Ogata, N; Saeki, K; Yoshikawa, T, 2021) |
| "The serum levels of two dimethylarginines, ADMA and SDMA, are associated with advanced glaucoma." | 7.78 | Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma. ( Abhary, S; Burdon, KP; Craig, JE; Hewitt, AW; Javadiyan, S; Mills, RA; Straga, T; Whiting, MJ, 2012) |
| "Hyperhomocysteinemia (HH), oxidative stress and endothelial dysfunction are all implicated as possible pathogenetic factors in exfoliation syndrome (XFS) and exfoliative glaucoma (XFG)." | 7.74 | Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma. ( Blomster, H; Kontkanen, M; Puustjärvi, T; Teräsvirta, M; Uusitalo, H; Valtonen, P, 2007) |
| "Asymmetric dimethylarginine (ADMA), a potent endogenous inhibitor of nitric oxide synthase, may be involved in the pathophysiology of glaucoma by dysfunctioning nitric oxide and oxidative stress." | 4.02 | Association Between the Asymmetric Dimethylarginine Levels and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study. ( Miyata, K; Obayashi, K; Ogata, N; Saeki, K; Yoshikawa, T, 2021) |
| "The serum levels of two dimethylarginines, ADMA and SDMA, are associated with advanced glaucoma." | 3.78 | Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma. ( Abhary, S; Burdon, KP; Craig, JE; Hewitt, AW; Javadiyan, S; Mills, RA; Straga, T; Whiting, MJ, 2012) |
| "Hyperhomocysteinemia (HH), oxidative stress and endothelial dysfunction are all implicated as possible pathogenetic factors in exfoliation syndrome (XFS) and exfoliative glaucoma (XFG)." | 3.74 | Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma. ( Blomster, H; Kontkanen, M; Puustjärvi, T; Teräsvirta, M; Uusitalo, H; Valtonen, P, 2007) |
| "Glaucoma is reportedly associated with asymmetric dimethylarginine (ADMA) and circadian blood pressure (BP) variability, including night-time SBP." | 1.91 | Circadian blood pressure variability and asymmetric dimethylarginine in patients with glaucoma: cross-sectional study of The LIGHT cohort. ( Jimura, H; Miyata, K; Obayashi, K; Ogata, N; Saeki, K; Yoshikawa, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshikawa, T | 2 |
| Obayashi, K | 2 |
| Miyata, K | 2 |
| Jimura, H | 1 |
| Saeki, K | 2 |
| Ogata, N | 2 |
| Javadiyan, S | 1 |
| Burdon, KP | 1 |
| Whiting, MJ | 1 |
| Abhary, S | 1 |
| Straga, T | 1 |
| Hewitt, AW | 1 |
| Mills, RA | 1 |
| Craig, JE | 1 |
| Blomster, H | 1 |
| Puustjärvi, T | 1 |
| Kontkanen, M | 1 |
| Valtonen, P | 1 |
| Teräsvirta, M | 1 |
| Uusitalo, H | 1 |
4 other studies available for n(g),n(g')-dimethyl-l-arginine and Glaucoma
| Article | Year |
|---|---|
Circadian blood pressure variability and asymmetric dimethylarginine in patients with glaucoma: cross-sectional study of The LIGHT cohort.
Topics: Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Sectional Studies; Gl | 2023 |
Association Between the Asymmetric Dimethylarginine Levels and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study.
Topics: Aged; Arginine; Biomarkers; Cross-Sectional Studies; Female; Follow-Up Studies; Glaucoma; Humans; In | 2021 |
Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
Topics: Aged; Arginine; Biomarkers; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Male; | 2012 |
Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
Topics: Aged; Arginine; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Exfoliation Syndrome; | 2007 |